Arcus Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $33,000 | $26,000 | $160,000 | $28,000 |
Gross Profit | 30,000 | 24,000 | 160,000 | 28,000 |
EBITDA | -81,000 | -130,000 | 4,000 | -108,000 |
EBIT | -84,000 | -132,000 | 2,000 | -111,000 |
Net Income | -98,000 | -135,000 | -8,000 | -112,000 |
Net Change In Cash | 33,000 | 26,000 | 160,000 | 28,000 |
Free Cash Flow | -121,000 | -97,000 | -133,000 | -133,000 |
Cash | 222,000 | 238,000 | 248,000 | 192,000 |
Basic Shares | 107,400 | 106,500 | 106,500 | 98,400 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $247,000 | $258,000 | $117,000 | $112,000 |
Gross Profit | 237,000 | 258,000 | 117,000 | 112,000 |
EBITDA | -335,000 | -269,000 | -291,000 | -258,000 |
EBIT | -345,000 | -279,000 | -299,000 | -264,000 |
Net Income | -353,000 | -283,000 | -307,000 | -267,000 |
Net Change In Cash | 247,000 | 258,000 | 117,000 | 112,000 |
Free Cash Flow | -484,000 | -176,000 | -330,000 | 432,000 |
Cash | 222,000 | 150,000 | 127,000 | 206,000 |
Basic Shares | 107,400 | 90,100 | 74,000 | 72,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.89 |
2025-09-30 | -$1.27 |
2025-06-30 | $0 |
